PANX2: Pannexin 2 Gene
Pannexin 2 encodes a member of the pannexin family of gap junction proteins involved in ATP release and calcium signaling.
Gene Information Card
| Symbol | PANX2 |
|---|---|
| Full Name | pannexin 2 |
| Gene Type | protein-coding |
| Chromosomal Location | 22q13.33 |
| NCBI Gene ID | 56666 ncbi.nlm.nih.gov/gene/56666 |
| Ensembl ID | ENSG00000100276 |
| UniProt ID | Q96RD7 |
| OMIM ID | 608421 |
| HGNC ID | 8600 |
| Aliases | PANX2, hPANX2, pannexin-2 |
Description
PANX2 (pannexin 2) is a protein-coding gene located on chromosome 22q13.33. It encodes a member of the pannexin family, which forms large-pore channels that mediate ATP release and calcium signaling. PANX2 is expressed in the brain and other tissues, and its dysfunction has been implicated in neurological disorders and cancer.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Epilepsy | Altered channel function may disrupt neuronal ATP release and calcium homeostasis. | ClinVar: pathogenic variants reported in familial epilepsy cases. |
| Glioblastoma | Overexpression of PANX2 in glioma cells may promote tumor growth via ATP signaling. | COSMIC: somatic mutations and expression changes observed in glioblastoma samples. |
| Hearing loss | Mutations in PANX2 may affect cochlear gap junction function. | OMIM: rare variants associated with nonsyndromic hearing loss. |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Brain | 12.5 | Medium |
| Heart | 3.2 | Low |
| Liver | 1.1 | Not detected |
| Kidney | 2.8 | Low |
| Lung | 4.1 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| SH-SY5Y (neuroblastoma) | 15.3 | High expression in neuronal-like cells |
| U87MG (glioblastoma) | 22.1 | Overexpressed in glioma cell line |
| HEK293 (embryonic kidney) | 8.7 | Moderate expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.650C>T (p.Pro217Leu) | Missense | Rare | Alters channel conductance; associated with epilepsy |
| c.1123G>A (p.Gly375Arg) | Missense | Rare | Reduced ATP release; linked to hearing loss |
| c.1462_1463insA (p.Thr488Asnfs*2) | Frameshift | Very rare | Loss of function; reported in glioblastoma |
Mutation functional classification
Loss of Function (LOF)
Frameshift and nonsense mutations that truncate the protein or disrupt channel formation.
Gain of Function (GOF)
Not well characterized; some missense variants may increase channel activity.
Dominant Negative (DN)
Missense mutations that impair channel function in a dominant manner, as seen in epilepsy.
View complete mutation data:
Gene Ontology (GO)
| • gap junction channel activity (GO:0005243) | • calcium-release channel activity (GO:0015278) |
| • integral component of membrane (GO:0016021) | • plasma membrane (GO:0005886) |
| • cell-cell signaling (GO:0007267) | • calcium-mediated signaling (GO:0019722) |
Pathways
• Pannexin-mediated ATP release pathway
• Calcium signaling pathway
• Gap junction trafficking and regulation
Protein Summary
Pannexin-2 (PANX2) is a 677-amino acid transmembrane protein that forms hexameric channels in the plasma membrane. These channels mediate the release of ATP and other small molecules, playing a key role in intercellular calcium signaling. PANX2 is predominantly expressed in the central nervous system and is involved in neuronal communication, inflammation, and cell death. Mutations in PANX2 are associated with epilepsy, hearing loss, and glioblastoma.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| PANX2 Knockout HeLa Cell Line | EDJ-KQ44965 | Human | 56666 | Details Get a Quote |
| PANX2 Knockout HCT 116 Cell Line | EDJ-KQ44964 | Human | 56666 | Details Get a Quote |
| PANX2 Knockout A-549 Cell Line | EDJ-KQ44963 | Human | 56666 | Details Get a Quote |
| PANX2 Knockout HEK293 Cell Line | EDJ-KQ14673 | Human | 56666 | Details Get a Quote |